chr2-216049372-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_018441.6(PECR):c.605G>A(p.Gly202Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000417 in 1,366,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018441.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PECR | NM_018441.6 | c.605G>A | p.Gly202Glu | missense_variant, splice_region_variant | 6/8 | ENST00000265322.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PECR | ENST00000265322.8 | c.605G>A | p.Gly202Glu | missense_variant, splice_region_variant | 6/8 | 1 | NM_018441.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000759 AC: 19AN: 250394Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135498
GnomAD4 exome AF: 0.0000206 AC: 25AN: 1214288Hom.: 0 Cov.: 18 AF XY: 0.0000178 AC XY: 11AN XY: 617116
GnomAD4 genome AF: 0.000210 AC: 32AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2022 | The c.605G>A (p.G202E) alteration is located in exon 6 (coding exon 6) of the PECR gene. This alteration results from a G to A substitution at nucleotide position 605, causing the glycine (G) at amino acid position 202 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at